Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study

Autor:	McBride, Ali *, Daniel, Shoshana, Driessen, Maurice T., Szende, Agota, Choudhry, Azhar, Tian, Marc, Ariely, Rinat, Thompson, Stephen
Zdroj:	In Leukemia Research December 2021 111
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect